Liquidia’s PRINT® platform has the ability to rapidly design and manufacture precisely engineered particles in a wide variety of size, shape, and compositions. This presentation will focus on the application of PRINT® to non-oral drug delivery.  A description of the PRINT® fabrication process will be followed by a discussion of some of the benefits of the technology to non-oral drug delivery. A more in depth discussion of non-oral applications will include in vitro and in vivo results from preclinical studies using the PRINT® particles for pulmonary delivery.  <br/>

Fabricated nano and microparticles for non-oral delivery

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.